Searchable abstracts of presentations at key conferences in endocrinology

ea0005p44 | Clinical Case Reports | BES2003

Cyclical Cushing's syndrome associated with a pituitary gonadotrophinoma

Acharya S , Jones T , Suliman M , Park C , Watson W , Abraham P , Bevan J

Background: True cyclical Cushing's syndrome is rare and usually due to an ACTH-secreting corticotrophinoma. We describe a man with cyclical Cushing's syndrome of 15 years duration who had unexpected pituitary immunohistopathology.Clinical details: A 22-year-old man presented in 1986 with clinical features of Cushing's syndrome & urinary free cortisols up to 1800 nmol/24h, but normal low-dose DXM suppression, & normal pituitary and adrenals on CT. He was then lost ...

ea0005p120 | Endocrine Tumours and Neoplasia | BES2003

Clinical and biochemical prognostic indicators at diagnosis in 117 midgut carcinoid tumours

Turner G , Johnston B , McCance D , Watson R , Buchanan K , Ardill J

Background/Aims: Prognosis in midgut carcinoid tumours (MGCs) is difficult to predict. Studies of traditional clinical parameters give conflicting results. This is a large retrospective survival analysis of both clinical and biochemical data collected at diagnosis before treatment.Methods: Sequential cases of MGCs were identified using a database in Belfast from 1978. Clinical notes and pre-treatment plasma Neurokinin A (NKA) concentrations, were reviewed for each patient ...

ea0003p36 | Clinical Case Reports | BES2002

Efficacy and safety of high dose testosterone therapy in partial androgen insensitivity

Bandyopadhyay S , Watson W , Park C , Abraham P , Philip S , Acharya S , Bevan J

Efficacy and Safety of High Dose Testosterone Therapy in Partial Androgen InsensitivityS. Bandyopadhyay, W.A.Watson, C. M.Park, P. Abraham, S. Philip, S. Acharya , J.S. Bevan. Department of Endocrinology, Aberdeen Royal Infirmary, Aberdeen, AB25 2ZN.INTRODUCTION: There have been few reports of the efficacy and safety of high dose androgen therapy in men with partial androgen insensitivity (PAI). We report on the responses of a p...

ea0003p40 | Clinical Case Reports | BES2002

Differentiated thyroid carcinoma with large bony metastases - what is the best approach?

Watson W , Park C , Abraham P , Bandyopadhyay S , Philip S , Acharya S , Samuel L , Bevan J

The high survival rate for patients with differentiated thyroid carcinoma (DTC) declines markedly in those with bony metastases. We compare the management of two patients with large dominant pelvic metastases.Case 1 63 year old man with R hip pain. Investigation revealed a 10cm lesion in the R hemi pelvis and subsequent imaging and biopsy revealed a 9th rib lesion and metastatic follicular DTC. He underwent 131 I ablation of the normal thyroi...

ea0056p662 | Female Reproduction | ECE2018

Cardiac evaluation in turner syndrome: echocardiography versus cardiac magnetic resonance

Calanchini Matilde , Orchard Elizabeth , Myerson Saul , McMillan Fiona , Bradley-Watson Jason , Fabbri Andrea , Turner Helen E

Introduction: Women with turner syndrome (TS) have an increased risk of aortic dissection at young age. Bicuspid aortic valve (BAV) and aortic dilatation, both associated with TS, are risk factors. Preliminary studies suggested that cardiac MR (CMR) perfoms better than transthoracic echocardiography (TTE) for evaluating BAV and aortic dilatation, probably related to the frequent chest abnormalities in TS.Aim: To evaluate the ability and comparability of ...

ea0037gp.15.01 | Diabetes and obesity – basic | ECE2015

Topical application of CD362+ human mesenchymal stem cells (cyndacel-M) seeded in Excellagen scaffold augments wound healing and increases angiogenesis in a diabetic rabbit ulcer model

Patil Swapnil , Chen Xizhe , Watson Luke , Loftus Paul , Flynn Lisa O' , Chandler Lois , Rubanyi Gabor , Elliman Stephen , O'Brien Timothy

Non-healing foot ulcers are a major complication in diabetic patients. Mesenchymal stem cells (MSCs) are known to promote angiogenesis with improved wound healing. Orbsen Therapeutics has identified a novel antibody (CD362+) which can be used to prospectively FACS-isolate CD362+CD45− MSC from human bone marrow with enhanced MSC/MNC purity ratios of up to 1/4. Excellagen matrix was used to seed the cells as biomaterials are well reported t...

ea0037ep275 | Calcium and Vitamin D metabolism | ECE2015

Acquired FGF23 resistance: the primacy of parathyroid hormone over fibroblast growth factor 23 in renal phosphorus handling

McKenna Malachi , Kinsella Sinead , Morrin Michelle , Sloman Melissa , Abdalla Ahad , O'Keane Myra , Murray Barbara , Holian John , Watson Alan , Kilbane Mark

Introduction: Fibroblast growth factor 23 (FGF23) excess is the cause of chronic hypophosphatemia in rare conditions such as X-linked hypophosphataemic rickets (XLHR) and tumour-induced osteomalacia (TIO), but animal studies indicate that the effect of FGF23 on serum phosphorus is dependent on the presence of parathyroid hormone (PTH). In this case series of rare disorders with abnormalities in renal phosphorus handling, we sought to explore the relative roles of PTH and FGF23...

ea0032p332 | Developmental Endocrinology | ECE2013

Crystal structure of the complex between an insulin-like peptide (DILP5) and an ILP binding protein (IMP-L2) from Drosophila melanogaster

Kulahin Nikolaj , Watson Christopher J , Sajid Waseem , Schluckebier Gerd , Andersen Asser S , Brzozowski Andrzej M , De Meyts Pierre

The insulin signalling system including the insulin receptor tyrosine kinase (IRTK) is evolutionarily ancient and appears in the first multicellular organisms (Cnidarians). The Drosophila melanogaster genome contains seven genes for insulin-like peptides (ILPs) that are expressed in neurosecretory cells in a highly tissue- and stage-specific pattern, DILP1-7. There is however only one IRTK (dIR). This system is important in the regulation of metabolism, growth, reprod...

ea0029oc1.2 | Pituitary Clinical I | ICEECE2012

Patients with Cushing’s disease achieve normal urinary cortisol with LCI699, a potent 11β-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study

Bertagna X. , Pivonello R. , Fleseriu M. , Zhang Y. , Robinson P. , Taylor A. , Watson C. , Maldonado M. , Hamrahian A. , Boscaro M. , Biller B.

Introduction: The clinical features and complications of Cushing’s syndrome result from chronic excess of circulating cortisol, typically quantified by 24-h urinary free cortisol (UFC). LCI699 is a potent inhibitor of 11β-hydroxylase. Since 11β-hydroxylase catalyzes the final step of cortisol synthesis, LCI699 is a potential new treatment for all forms of Cushing’s syndrome.Methods: Adult patients with mild-to-severe Cushing’s di...

ea0003p48 | Clinical Case Reports | BES2002

Multidisciplinary management of Cushing's syndrome due to a malignant thymic carcinoid tumour

Park C , Watson W , Abraham P , Acharya S , Bandyopadhyay S , Philip S , Samuel L , Nicolson M , Bevan J

Thymic carcinoma is a rare but aggressive cause of ectopic ACTH secretion, with fewer than 100 reported cases.Hypokalaemic alkalosis was found in a 38 year old woman who presented with a 2-week history of leg swelling, fatigue and dyspnoea. She was not obviously Cushingoid.ACTH-dependent Cushing's Syndrome was confirmed biochemically: urinary free cortisol (UFC) >8500nmol/day and serum cortisol 4060nmol/l, (no suppression on 8...